SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-165255
Filing Date
2018-05-16
Accepted
2018-05-16 16:13:03
Documents
5
Effectiveness Date
2018-05-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A d553755ddefa14a.htm DEFA14A 44366
2 GRAPHIC g553755imgg1.jpg GRAPHIC 16228
3 GRAPHIC g553755imgg2.jpg GRAPHIC 9191
4 GRAPHIC g553755imgg3.jpg GRAPHIC 20235
5 GRAPHIC g553755imgg5.jpg GRAPHIC 11429
  Complete submission text file 0001193125-18-165255.txt   124896
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33958 | Film No.: 18840111
SIC: 2834 Pharmaceutical Preparations